Angiogenesis and neoangiogenesis;ANGIOGENESE ET NEOANGIOGENESE

Revue du Praticien

Volumn 47, Issue 20, 1997, Pages 2239-2243

  Savona, Catherine ^a   Javerzat, Sophie ^a   Perollet, Catherine ^a   Blkfalvi, Andreas ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; VASCULOTROPIN; ANGIOGENIC FACTOR; UROKINASE;

ANGIOGENESIS; CORPUS LUTEUM; DRUG ACTIVITY; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; SHORT SURVEY; SOLID TUMOR; WOUND HEALING; ARTICLE; DRUG EFFECT; ENZYMOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INDUCING AGENTS; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031573653     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (19)

1. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18:4-25.
2. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of flbroblast growth factor2 (FGF-2). Endocr Rev 1997; 18: 26-45.
3. Folkman J, D'Amore PA. Blood vessel formation : What is its molecular basis ? Cell 1996;87: 1153-5.
4. Maisonpierre PC, Suri C, Jones PF et al. Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
5. D'Angelo G, Struman I, Martial J, Weiner RI. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 1995 ; 92: 6374-8.
6. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblast by p53 regulation of thrombospondin-1. Science 1994; 265: 1582-4.
7. Volpert OV, Stellmach V, Bouck N. The modulation of thrombospondin and other naturally occuring inhibitors of angiogenesis during tumor progression. Breast Cancer Res Treat 1995; 36: 119-26.
8. 8.0'Reilly MS, Boehm T, Shing Y et al Endostatin : An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997 ; 88 : 277-85.
9. O'Reilly MS, Holmgren L, Chen C, Folkman j. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996; 2: 689-92.
10. Dong Z, Kumar R, Yang X, Fidler IJ. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewiw lung carcinoma. Cell 1997 ; 88:801-10.
11. I. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic swith during tumorigenesis. Cell 1996 ; 86 : 353-64.
12. Pintucci G, Bikfalvi A, Klein S, Rifkin DB. Angiogenesis and the fibrinolytic system. Semin Thromb Hemost 1996 ; 22:517-24.
13. Hori A, Sasada R, Matsutani E et al. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 1991 ; 51: 6180-4.
14. Kim KJ, Li B, Winer J et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993 ; 362: 841 -6.
15. Hanahan D. Heritable formation of pancreatic cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985 ; 315 : 115-321.
16. Parangi S, O'Reilly MS, Christofori G et al. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc Natl Acad Sci USA 1996; 93: 2002-7.
17. Isner JM, Pieczek A, Schainfeld R et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF 165 in patient with ischaemic limb. Lancet 1996 ; 348:370-4.
18. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995; 1:1024-8.
19. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LE. Oligodeoxynucleotides inhibit retinalneovascularization in a murine model of prolrferative retinopathy. Proc Natl Acad Sci USA 1996; 93: 4851-6.